Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer.
Full article >>
Monday, May 25, 2009
Novel Herbal Therapy For Men At High Risk Of Prostate Cancer Well-Tolerated In Phase I Trial
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment